Trial intelligence / Profile preview

Chronotherapy for Nocturnal Hypertension in Pediatric Renal Transplant

NCT01007994Phase 3Completed

Sponsor
Northwell Health
Start
Nov 2009
Primary completion
Jan 2020
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of enalapril, Isradipine, propranolol in hypertension (HTN), sponsored by Northwell Health. Started Nov 2009; status: completed.

02

Drugs

enalaprilIsradipinepropranolol
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT01007994.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01007994.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call